84 related articles for article (PubMed ID: 35378403)
1. Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].
Cantini L; Mentrasti G; Lo Russo G; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; La Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; Fancelli S; Caliman E; Della Gravara L; Malapelle U; Filetti M; Piras M; Toscano G; Zullo L; De Tursi M; Di Marino P; D'Emilio V; Cona MS; Guida A; Caglio A; Salerno F; Spinelli GP; Bennati C; Morgillo F; Russo A; Dellepiane C; Vallini I; Sforza V; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri MV; Emili R; Roca E; Migliore A; Galassi T; Rocchi MBL; Berardi R
ESMO Open; 2022 Apr; 7(2):100471. PubMed ID: 35378403
[No Abstract] [Full Text] [Related]
2. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
Cantini L; Mentrasti G; Russo GL; Signorelli D; Pasello G; Rijavec E; Russano M; Antonuzzo L; Rocco D; Giusti R; Adamo V; Genova C; Tuzi A; Morabito A; Gori S; Verde N; Chiari R; Cortellini A; Cognigni V; Pecci F; Indini A; De Toma A; Zattarin E; Oresti S; Pizzutilo EG; Frega S; Erbetta E; Galletti A; Citarella F; Fancelli S; Caliman E; Della Gravara L; Malapelle U; Filetti M; Piras M; Toscano G; Zullo L; De Tursi M; Di Marino P; D'Emilio V; Cona MS; Guida A; Caglio A; Salerno F; Spinelli G; Bennati C; Morgillo F; Russo A; Dellepiane C; Vallini I; Sforza V; Inno A; Rastelli F; Tassi V; Nicolardi L; Pensieri V; Emili R; Roca E; Migliore A; Galassi T; Rocchi MLB; Berardi R
ESMO Open; 2022 Apr; 7(2):100406. PubMed ID: 35219245
[TBL] [Abstract][Full Text] [Related]
3. Erratum to 'Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis': [ESMO Open Volume 6, Issue 2, April 2021, 100088].
Peleg Hasson S; Brezis MR; Shachar E; Shachar SS; Wolf I; Sonnenblick A
ESMO Open; 2021 Jun; 6(3):100158. PubMed ID: 34144779
[No Abstract] [Full Text] [Related]
4. Erratum to 'Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival': [ESMO Open Volume 7, Issue 2, April 2022, 100409].
Miglietta F; Bottosso M; Griguolo G; Dieci MV; Guarneri V
ESMO Open; 2022 Jun; 7(3):100472. PubMed ID: 35398607
[No Abstract] [Full Text] [Related]
5. Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005].
Lee RJ; Wysocki O; Bhogal T; Shotton R; Tivey A; Angelakas A; Aung T; Banfill K; Baxter M; Boyce H; Brearton G; Copson E; Dickens E; Eastlake L; Gomes F; Hague C; Harrison M; Horsley L; Huddar P; Hudson Z; Khan S; Khan UT; Maynard A; McKenzie H; Palmer D; Robinson T; Rowe M; Thomas A; Tweedy J; Sheehan R; Stockdale A; Weaver J; Williams S; Wilson C; Zhou C; Dive C; Cooksley T; Palmieri C; Freitas A; Armstrong AC
ESMO Open; 2021 Apr; 6(2):100056. PubMed ID: 33545518
[No Abstract] [Full Text] [Related]
6. Corrigendum to 'COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)': [ESMO Open Volume 6, Issue 3, June 2021, 100165].
Bianchi F; Dama E; Di Nicolantonio F; Baldassarre G; Guerriero I; Torchiaro E; Bruno A; Blandino G; Allavena P; Chiarugi P; Sozzi G; D'Incalci M; Normanno N
ESMO Open; 2021 Aug; 6(4):100243. PubMed ID: 34352704
[No Abstract] [Full Text] [Related]
7. Patterns of Delaying Surgery for Breast Cancer During the COVID-19 Outbreak in Daegu, South Korea.
Lee J; Jung JH; Kim WW; Park CS; Park HY
Front Surg; 2020; 7():576196. PubMed ID: 33134309
[No Abstract] [Full Text] [Related]
8. Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447].
Ochsenreither S; Fiedler WM; Del Conte G; Macchini M; Matos I; Habel B; Ahrens-Fath I; Raspagliesi F; Lorusso D; Keilholz U; Rolling C; Kebenko M; Klinghammer KF; Saavedra O; Baumeister H; Zurlo A; Garralda A
ESMO Open; 2022 Aug; 7(4):100549. PubMed ID: 35841804
[No Abstract] [Full Text] [Related]
9. Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
de Marinis F; Attili I; Morganti S; Stati V; Spitaleri G; Gianoncelli L; Del Signore E; Catania C; Rampinelli C; Omodeo Salè E; Spaggiari L; Mastrilli F; Passaro A
Front Oncol; 2020; 10():665. PubMed ID: 32391282
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078].
Banna GL; Cortellini A; Cortinovis DL; Tiseo M; Aerts JGJV; Barbieri F; Giusti R; Bria E; Grossi F; Pizzutilo P; Berardi R; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Gelibter A; Macerelli M; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Montrone M; Citarella F; Marco R; Cantini L; Nigro O; D'Argento E; Buti S; Minuti G; Landi L; Guaitoli G; Lo Russo G; De Toma A; Donisi C; Friedlaender A; De Giglio A; Metro G; Porzio G; Ficorella C; Addeo A
ESMO Open; 2021 Jun; 6(3):100137. PubMed ID: 34144775
[No Abstract] [Full Text] [Related]
11. Erratum to 'Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients': [ESMO Open Volume 7, Issue 1, February 2022, 100393].
Beechinor R; Palumbo A; Chew HK; Arora M
ESMO Open; 2022 Apr; 7(2):100460. PubMed ID: 35306439
[No Abstract] [Full Text] [Related]
12. Erratum to 'How we treat medulloblastoma in adults': [ESMO Open Volume 6, Issue 4, August 2021, 100173].
Franceschi E; Seidel C; Sahm F; Pajtler KW; Hau P
ESMO Open; 2021 Dec; 6(6):100327. PubMed ID: 34775301
[No Abstract] [Full Text] [Related]
13. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries.
Coloma PM; Valkhoff VE; Mazzaglia G; Nielsson MS; Pedersen L; Molokhia M; Mosseveld M; Morabito P; Schuemie MJ; van der Lei J; Sturkenboom M; Trifirò G;
BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794587
[TBL] [Abstract][Full Text] [Related]
14. Erratum to 'How we treat primary central nervous system lymphoma': [ESMO Open Volume 6, Issue 4, August 2021, 100213].
Calimeri T; Steffanoni S; Gagliardi F; Chiara A; Ferreri AJM
ESMO Open; 2021 Dec; 6(6):100326. PubMed ID: 34773905
[No Abstract] [Full Text] [Related]
15. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
Ottaviano M; Curvietto M; Rescigno P; Tortora M; Palmieri G; Giannarelli D; Aieta M; Assalone P; Attademo L; Avallone A; Bloise F; Bosso D; Borzillo V; Buono G; Calderoni G; Caputo F; Cartenì G; Cavallero D; Cavo A; Ciardiello F; Conca R; Conteduca V; De Falco S; De Felice M; De Laurentiis M; De Placido P; De Placido S; De Santo I; De Stefano A; Della Corte CM; Di Franco R; Di Lauro V; Fabbrocini A; Federico P; Festino L; Giordano P; Giuliano M; Gridelli C; Grimaldi AM; Lia M; Marretta AL; Massa V; Mennitto A; Merler S; Merz V; Messina C; Messina M; Milano M; Minisini AM; Montesarchio V; Morabito A; Morgillo F; Mucci B; Nappi L; Napolitano F; Paciolla I; Pagliuca M; Palmieri G; Parola S; Pepe S; Petrillo A; Piantedosi F; Piccin L; Picozzi F; Pietroluongo E; Pignata S; Prati V; Riccio V; Rosanova M; Rossi A; Russo A; Salati M; Santabarbara G; Sbrana A; Simeone E; Silvestri A; Spada M; Tarantino P; Taveggia P; Tomei F; Vincenzo T; Trapani D; Trojanello C; Vanella V; Vari S; Ventriglia J; Vitale MG; Vitiello F; Vivaldi C; von Arx C; Zacchi F; Zampiva I; Zivi A; Daniele B; Ascierto PA;
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060148
[TBL] [Abstract][Full Text] [Related]
16. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L; Conforti F; Saponara M; De Pas T; Giugliano F; Omodeo Salè E; Jemos C; Rubatto M; Agostini A; Quaglino P; Fava P; Fierro MT; Queirolo P
Semin Oncol; 2020 Oct; 47(5):302-304. PubMed ID: 32883537
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic on urology residency training in Italy.
Amparore D; Claps F; Cacciamani GE; Esperto F; Fiori C; Liguori G; Serni S; Trombetta C; Carini M; Porpiglia F; Checcucci E; Campi R
Minerva Urol Nefrol; 2020 Aug; 72(4):505-509. PubMed ID: 32253371
[TBL] [Abstract][Full Text] [Related]
18. Erratum to 'FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?': [ESMO Open Volume 5, Issue 5, 2020, e000633].
Lamarca A; Foster L; Satyadas T; Siriwardena A; Valle JW
ESMO Open; 2021 Jun; 6(3):100138. PubMed ID: 34144782
[No Abstract] [Full Text] [Related]
19. Corrigendum to 'Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study': [ESMO Open Volume 5, Issue 6, 2020, e000985].
Shi L; Xu C; Ma Y; Ou Q; Wu X; Lu S; Shao Y; Guo R; Kong J
ESMO Open; 2021 Feb; 6(1):100052. PubMed ID: 33497993
[No Abstract] [Full Text] [Related]
20. Effects of the COVID-19 Pandemic on Stroke Patients.
Ghanchi H; Takayanagi A; Savla P; Hariri OR; Tayag EC; Schiraldi M; Jorgensen L; Miulli DE
Cureus; 2020 Aug; 12(8):e9995. PubMed ID: 32983694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
